Global Drugs for Schistosomiasis Market Growth 2022-2028
As the global economy mends, the 2021 growth of Drugs for Schistosomiasis will have significant change from previous year. According to our latest study, the global Drugs for Schistosomiasis market size is USD million in 2022 from USD 80 million in 2021, with a change of % between 2021 and 2022. The global Drugs for Schistosomiasis market size will reach USD 105.1 million in 2028, growing at a CAGR of 3.9% over the analysis period.
The United States Drugs for Schistosomiasis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drugs for Schistosomiasis market, reaching US$ million by the year 2028. As for the Europe Drugs for Schistosomiasis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Drugs for Schistosomiasis players cover Shin Poong, Merck, Bayer, and EIPICO, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Schistosomiasis market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Praziquantel
Oxamniquine
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for Schistosomiasis Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Drugs for Schistosomiasis by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Drugs for Schistosomiasis by Country/Region, 2017, 2022 & 2028
2.2 Drugs for Schistosomiasis Segment by Type
2.2.1 Praziquantel
2.2.2 Oxamniquine
2.2.3 Other
2.3 Drugs for Schistosomiasis Sales by Type
2.3.1 Global Drugs for Schistosomiasis Sales Market Share by Type (2017-2022)
2.3.2 Global Drugs for Schistosomiasis Revenue and Market Share by Type (2017-2022)
2.3.3 Global Drugs for Schistosomiasis Sale Price by Type (2017-2022)
2.4 Drugs for Schistosomiasis Segment by Application
2.4.1 S. haematobium
2.4.2 S. mansoni
2.4.3 S. japonicum
2.4.4 S. mekongi
2.4.5 S. intercalatum
2.5 Drugs for Schistosomiasis Sales by Application
2.5.1 Global Drugs for Schistosomiasis Sale Market Share by Application (2017-2022)
2.5.2 Global Drugs for Schistosomiasis Revenue and Market Share by Application (2017-2022)
2.5.3 Global Drugs for Schistosomiasis Sale Price by Application (2017-2022)
3 Global Drugs for Schistosomiasis by Company
3.1 Global Drugs for Schistosomiasis Breakdown Data by Company
3.1.1 Global Drugs for Schistosomiasis Annual Sales by Company (2020-2022)
3.1.2 Global Drugs for Schistosomiasis Sales Market Share by Company (2020-2022)
3.2 Global Drugs for Schistosomiasis Annual Revenue by Company (2020-2022)
3.2.1 Global Drugs for Schistosomiasis Revenue by Company (2020-2022)
3.2.2 Global Drugs for Schistosomiasis Revenue Market Share by Company (2020-2022)
3.3 Global Drugs for Schistosomiasis Sale Price by Company
3.4 Key Manufacturers Drugs for Schistosomiasis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drugs for Schistosomiasis Product Location Distribution
3.4.2 Players Drugs for Schistosomiasis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Drugs for Schistosomiasis by Geographic Region
4.1 World Historic Drugs for Schistosomiasis Market Size by Geographic Region (2017-2022)
4.1.1 Global Drugs for Schistosomiasis Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Drugs for Schistosomiasis Annual Revenue by Geographic Region
4.2 World Historic Drugs for Schistosomiasis Market Size by Country/Region (2017-2022)
4.2.1 Global Drugs for Schistosomiasis Annual Sales by Country/Region (2017-2022)
4.2.2 Global Drugs for Schistosomiasis Annual Revenue by Country/Region
4.3 Americas Drugs for Schistosomiasis Sales Growth
4.4 APAC Drugs for Schistosomiasis Sales Growth
4.5 Europe Drugs for Schistosomiasis Sales Growth
4.6 Middle East & Africa Drugs for Schistosomiasis Sales Growth
5 Americas
5.1 Americas Drugs for Schistosomiasis Sales by Country
5.1.1 Americas Drugs for Schistosomiasis Sales by Country (2017-2022)
5.1.2 Americas Drugs for Schistosomiasis Revenue by Country (2017-2022)
5.2 Americas Drugs for Schistosomiasis Sales by Type
5.3 Americas Drugs for Schistosomiasis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Schistosomiasis Sales by Region
6.1.1 APAC Drugs for Schistosomiasis Sales by Region (2017-2022)
6.1.2 APAC Drugs for Schistosomiasis Revenue by Region (2017-2022)
6.2 APAC Drugs for Schistosomiasis Sales by Type
6.3 APAC Drugs for Schistosomiasis Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Drugs for Schistosomiasis by Country
7.1.1 Europe Drugs for Schistosomiasis Sales by Country (2017-2022)
7.1.2 Europe Drugs for Schistosomiasis Revenue by Country (2017-2022)
7.2 Europe Drugs for Schistosomiasis Sales by Type
7.3 Europe Drugs for Schistosomiasis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs for Schistosomiasis by Country
8.1.1 Middle East & Africa Drugs for Schistosomiasis Sales by Country (2017-2022)
8.1.2 Middle East & Africa Drugs for Schistosomiasis Revenue by Country (2017-2022)
8.2 Middle East & Africa Drugs for Schistosomiasis Sales by Type
8.3 Middle East & Africa Drugs for Schistosomiasis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drugs for Schistosomiasis
10.3 Manufacturing Process Analysis of Drugs for Schistosomiasis
10.4 Industry Chain Structure of Drugs for Schistosomiasis
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drugs for Schistosomiasis Distributors
11.3 Drugs for Schistosomiasis Customer
12 World Forecast Review for Drugs for Schistosomiasis by Geographic Region
12.1 Global Drugs for Schistosomiasis Market Size Forecast by Region
12.1.1 Global Drugs for Schistosomiasis Forecast by Region (2023-2028)
12.1.2 Global Drugs for Schistosomiasis Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drugs for Schistosomiasis Forecast by Type
12.7 Global Drugs for Schistosomiasis Forecast by Application
13 Key Players Analysis
13.1 Shin Poong
13.1.1 Shin Poong Company Information
13.1.2 Shin Poong Drugs for Schistosomiasis Product Offered
13.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Shin Poong Main Business Overview
13.1.5 Shin Poong Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Drugs for Schistosomiasis Product Offered
13.2.3 Merck Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Drugs for Schistosomiasis Product Offered
13.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 EIPICO
13.4.1 EIPICO Company Information
13.4.2 EIPICO Drugs for Schistosomiasis Product Offered
13.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 EIPICO Main Business Overview
13.4.5 EIPICO Latest Developments
13.5 Chandra Bhagat Pharma
13.5.1 Chandra Bhagat Pharma Company Information
13.5.2 Chandra Bhagat Pharma Drugs for Schistosomiasis Product Offered
13.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Chandra Bhagat Pharma Main Business Overview
13.5.5 Chandra Bhagat Pharma Latest Developments
13.6 Taj Pharmaceuticals
13.6.1 Taj Pharmaceuticals Company Information
13.6.2 Taj Pharmaceuticals Drugs for Schistosomiasis Product Offered
13.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Taj Pharmaceuticals Main Business Overview
13.6.5 Taj Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Drugs for Schistosomiasis Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Drugs for Schistosomiasis Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Praziquantel
Table 4. Major Players of Oxamniquine
Table 5. Major Players of Other
Table 6. Global Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 7. Global Drugs for Schistosomiasis Sales Market Share by Type (2017-2022)
Table 8. Global Drugs for Schistosomiasis Revenue by Type (2017-2022) & ($ million)
Table 9. Global Drugs for Schistosomiasis Revenue Market Share by Type (2017-2022)
Table 10. Global Drugs for Schistosomiasis Sale Price by Type (2017-2022) & (USD/K Units)
Table 11. Global Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 12. Global Drugs for Schistosomiasis Sales Market Share by Application (2017-2022)
Table 13. Global Drugs for Schistosomiasis Revenue by Application (2017-2022)
Table 14. Global Drugs for Schistosomiasis Revenue Market Share by Application (2017-2022)
Table 15. Global Drugs for Schistosomiasis Sale Price by Application (2017-2022) & (USD/K Units)
Table 16. Global Drugs for Schistosomiasis Sales by Company (2020-2022) & (M Units)
Table 17. Global Drugs for Schistosomiasis Sales Market Share by Company (2020-2022)
Table 18. Global Drugs for Schistosomiasis Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Drugs for Schistosomiasis Revenue Market Share by Company (2020-2022)
Table 20. Global Drugs for Schistosomiasis Sale Price by Company (2020-2022) & (USD/K Units)
Table 21. Key Manufacturers Drugs for Schistosomiasis Producing Area Distribution and Sales Area
Table 22. Players Drugs for Schistosomiasis Products Offered
Table 23. Drugs for Schistosomiasis Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Drugs for Schistosomiasis Sales by Geographic Region (2017-2022) & (M Units)
Table 27. Global Drugs for Schistosomiasis Sales Market Share Geographic Region (2017-2022)
Table 28. Global Drugs for Schistosomiasis Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Drugs for Schistosomiasis Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Drugs for Schistosomiasis Sales by Country/Region (2017-2022) & (M Units)
Table 31. Global Drugs for Schistosomiasis Sales Market Share by Country/Region (2017-2022)
Table 32. Global Drugs for Schistosomiasis Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Drugs for Schistosomiasis Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
Table 35. Americas Drugs for Schistosomiasis Sales Market Share by Country (2017-2022)
Table 36. Americas Drugs for Schistosomiasis Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Drugs for Schistosomiasis Revenue Market Share by Country (2017-2022)
Table 38. Americas Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 39. Americas Drugs for Schistosomiasis Sales Market Share by Type (2017-2022)
Table 40. Americas Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 41. Americas Drugs for Schistosomiasis Sales Market Share by Application (2017-2022)
Table 42. APAC Drugs for Schistosomiasis Sales by Region (2017-2022) & (M Units)
Table 43. APAC Drugs for Schistosomiasis Sales Market Share by Region (2017-2022)
Table 44. APAC Drugs for Schistosomiasis Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Drugs for Schistosomiasis Revenue Market Share by Region (2017-2022)
Table 46. APAC Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 47. APAC Drugs for Schistosomiasis Sales Market Share by Type (2017-2022)
Table 48. APAC Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 49. APAC Drugs for Schistosomiasis Sales Market Share by Application (2017-2022)
Table 50. Europe Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
Table 51. Europe Drugs for Schistosomiasis Sales Market Share by Country (2017-2022)
Table 52. Europe Drugs for Schistosomiasis Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Drugs for Schistosomiasis Revenue Market Share by Country (2017-2022)
Table 54. Europe Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 55. Europe Drugs for Schistosomiasis Sales Market Share by Type (2017-2022)
Table 56. Europe Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 57. Europe Drugs for Schistosomiasis Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
Table 59. Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Drugs for Schistosomiasis Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Drugs for Schistosomiasis Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 63. Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 65. Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Drugs for Schistosomiasis
Table 67. Key Market Challenges & Risks of Drugs for Schistosomiasis
Table 68. Key Industry Trends of Drugs for Schistosomiasis
Table 69. Drugs for Schistosomiasis Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Drugs for Schistosomiasis Distributors List
Table 72. Drugs for Schistosomiasis Customer List
Table 73. Global Drugs for Schistosomiasis Sales Forecast by Region (2023-2028) & (M Units)
Table 74. Global Drugs for Schistosomiasis Sales Market Forecast by Region
Table 75. Global Drugs for Schistosomiasis Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Drugs for Schistosomiasis Sales Forecast by Country (2023-2028) & (M Units)
Table 78. Americas Drugs for Schistosomiasis Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Drugs for Schistosomiasis Sales Forecast by Region (2023-2028) & (M Units)
Table 80. APAC Drugs for Schistosomiasis Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Drugs for Schistosomiasis Sales Forecast by Country (2023-2028) & (M Units)
Table 82. Europe Drugs for Schistosomiasis Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Drugs for Schistosomiasis Sales Forecast by Country (2023-2028) & (M Units)
Table 84. Middle East & Africa Drugs for Schistosomiasis Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Drugs for Schistosomiasis Sales Forecast by Type (2023-2028) & (M Units)
Table 86. Global Drugs for Schistosomiasis Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Drugs for Schistosomiasis Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Drugs for Schistosomiasis Sales Forecast by Application (2023-2028) & (M Units)
Table 90. Global Drugs for Schistosomiasis Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Drugs for Schistosomiasis Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Drugs for Schistosomiasis Revenue Market Share Forecast by Application (2023-2028)
Table 93. Shin Poong Basic Information, Drugs for Schistosomiasis Manufacturing Base, Sales Area and Its Competitors
Table 94. Shin Poong Drugs for Schistosomiasis Product Offered
Table 95. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)
Table 96. Shin Poong Main Business
Table 97. Shin Poong Latest Developments
Table 98. Merck Basic Information, Drugs for Schistosomiasis Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Drugs for Schistosomiasis Product Offered
Table 100. Merck Drugs for Schistosomiasis Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Bayer Basic Information, Drugs for Schistosomiasis Manufacturing Base, Sales Area and Its Competitors
Table 104. Bayer Drugs for Schistosomiasis Product Offered
Table 105. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)
Table 106. Bayer Main Business
Table 107. Bayer Latest Developments
Table 108. EIPICO Basic Information, Drugs for Schistosomiasis Manufacturing Base, Sales Area and Its Competitors
Table 109. EIPICO Drugs for Schistosomiasis Product Offered
Table 110. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)
Table 111. EIPICO Main Business
Table 112. EIPICO Latest Developments
Table 113. Chandra Bhagat Pharma Basic Information, Drugs for Schistosomiasis Manufacturing Base, Sales Area and Its Competitors
Table 114. Chandra Bhagat Pharma Drugs for Schistosomiasis Product Offered
Table 115. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)
Table 116. Chandra Bhagat Pharma Main Business
Table 117. Chandra Bhagat Pharma Latest Developments
Table 118. Taj Pharmaceuticals Basic Information, Drugs for Schistosomiasis Manufacturing Base, Sales Area and Its Competitors
Table 119. Taj Pharmaceuticals Drugs for Schistosomiasis Product Offered
Table 120. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)
Table 121. Taj Pharmaceuticals Main Business
Table 122. Taj Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Drugs for Schistosomiasis
Figure 2. Drugs for Schistosomiasis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drugs for Schistosomiasis Sales Growth Rate 2017-2028 (M Units)
Figure 7. Global Drugs for Schistosomiasis Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Drugs for Schistosomiasis Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Praziquantel
Figure 10. Product Picture of Oxamniquine
Figure 11. Product Picture of Other
Figure 12. Global Drugs for Schistosomiasis Sales Market Share by Type in 2021
Figure 13. Global Drugs for Schistosomiasis Revenue Market Share by Type (2017-2022)
Figure 14. Drugs for Schistosomiasis Consumed in S. haematobium
Figure 15. Global Drugs for Schistosomiasis Market: S. haematobium (2017-2022) & (M Units)
Figure 16. Drugs for Schistosomiasis Consumed in S. mansoni
Figure 17. Global Drugs for Schistosomiasis Market: S. mansoni (2017-2022) & (M Units)
Figure 18. Drugs for Schistosomiasis Consumed in S. japonicum
Figure 19. Global Drugs for Schistosomiasis Market: S. japonicum (2017-2022) & (M Units)
Figure 20. Drugs for Schistosomiasis Consumed in S. mekongi
Figure 21. Global Drugs for Schistosomiasis Market: S. mekongi (2017-2022) & (M Units)
Figure 22. Drugs for Schistosomiasis Consumed in S. intercalatum
Figure 23. Global Drugs for Schistosomiasis Market: S. intercalatum (2017-2022) & (M Units)
Figure 24. Global Drugs for Schistosomiasis Sales Market Share by Application (2017-2022)
Figure 25. Global Drugs for Schistosomiasis Revenue Market Share by Application in 2021
Figure 26. Drugs for Schistosomiasis Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Drugs for Schistosomiasis Revenue Market Share by Company in 2021
Figure 28. Global Drugs for Schistosomiasis Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Drugs for Schistosomiasis Revenue Market Share by Geographic Region in 2021
Figure 30. Global Drugs for Schistosomiasis Sales Market Share by Region (2017-2022)
Figure 31. Global Drugs for Schistosomiasis Revenue Market Share by Country/Region in 2021
Figure 32. Americas Drugs for Schistosomiasis Sales 2017-2022 (M Units)
Figure 33. Americas Drugs for Schistosomiasis Revenue 2017-2022 ($ Millions)
Figure 34. APAC Drugs for Schistosomiasis Sales 2017-2022 (M Units)
Figure 35. APAC Drugs for Schistosomiasis Revenue 2017-2022 ($ Millions)
Figure 36. Europe Drugs for Schistosomiasis Sales 2017-2022 (M Units)
Figure 37. Europe Drugs for Schistosomiasis Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Drugs for Schistosomiasis Sales 2017-2022 (M Units)
Figure 39. Middle East & Africa Drugs for Schistosomiasis Revenue 2017-2022 ($ Millions)
Figure 40. Americas Drugs for Schistosomiasis Sales Market Share by Country in 2021
Figure 41. Americas Drugs for Schistosomiasis Revenue Market Share by Country in 2021
Figure 42. United States Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Drugs for Schistosomiasis Sales Market Share by Region in 2021
Figure 47. APAC Drugs for Schistosomiasis Revenue Market Share by Regions in 2021
Figure 48. China Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Drugs for Schistosomiasis Sales Market Share by Country in 2021
Figure 55. Europe Drugs for Schistosomiasis Revenue Market Share by Country in 2021
Figure 56. Germany Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Drugs for Schistosomiasis Revenue Market Share by Country in 2021
Figure 63. Egypt Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Drugs for Schistosomiasis Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Drugs for Schistosomiasis in 2021
Figure 69. Manufacturing Process Analysis of Drugs for Schistosomiasis
Figure 70. Industry Chain Structure of Drugs for Schistosomiasis
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
